429 related articles for article (PubMed ID: 32961235)
1. Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice.
Liu Q; Cai BY; Zhu LX; Xin X; Wang X; An ZM; Li S; Hu YY; Feng Q
Life Sci; 2020 Nov; 261():118457. PubMed ID: 32961235
[TBL] [Abstract][Full Text] [Related]
2. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
[TBL] [Abstract][Full Text] [Related]
3. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
4. Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
Kamm DR; Pyles KD; Sharpe MC; Healy LN; Colca JR; McCommis KS
J Biol Chem; 2021; 296():100807. PubMed ID: 34022222
[TBL] [Abstract][Full Text] [Related]
5. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
6. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice.
Moreira GV; Azevedo FF; Ribeiro LM; Santos A; Guadagnini D; Gama P; Liberti EA; Saad M; Carvalho C
J Nutr Biochem; 2018 Dec; 62():143-154. PubMed ID: 30292107
[TBL] [Abstract][Full Text] [Related]
8. The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet.
Somm E; Montandon SA; Loizides-Mangold U; Gaïa N; Lazarevic V; De Vito C; Perroud E; Bochaton-Piallat ML; Dibner C; Schrenzel J; Jornayvaz FR
Transl Res; 2021 Jan; 227():75-88. PubMed ID: 32711187
[TBL] [Abstract][Full Text] [Related]
9. Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition.
Chen J; Ding X; Wu R; Tong B; Zhao L; Lv H; Meng X; Liu Y; Ren B; Li J; Jian T; Li W
J Agric Food Chem; 2021 Dec; 69(47):14176-14191. PubMed ID: 34783554
[TBL] [Abstract][Full Text] [Related]
10. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet.
Zhang N; Tao J; Gao L; Bi Y; Li P; Wang H; Zhu D; Feng W
Biomed Res Int; 2020; 2020():2947549. PubMed ID: 32149099
[TBL] [Abstract][Full Text] [Related]
16. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
17. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis].
Zou JJ; Li H; Zhou M; Huang QQ; Wu YJ; Yu R
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242
[TBL] [Abstract][Full Text] [Related]
18. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
Lee JE; Lee SM; Jung J
Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
[TBL] [Abstract][Full Text] [Related]
19. Dietary fiber of Tartary buckwheat bran modified by steam explosion alleviates hyperglycemia and modulates gut microbiota in db/db mice.
He X; Li W; Chen Y; Lei L; Li F; Zhao J; Zeng K; Ming J
Food Res Int; 2022 Jul; 157():111386. PubMed ID: 35761642
[TBL] [Abstract][Full Text] [Related]
20. [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances].
Liu Y; Feng PP; Zhu W; Gong JP
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):473-476. PubMed ID: 28763870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
